Gilead Stock News

The Goldman Sachs Group assumed coverage on shares of Gilead Sciences (NASDAQ:GILD) in a research report report published on Monday morning, PriceTargets.com reports. The firm issued a neutral rating and a $80.00 price objective on the biopharmaceutical companys stock. GILD has been the topic of several other reports. BMO Capital Markets upgraded Gilead Sciences from []

Gilead Sciences Inc (Symbol: GILD) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average DividendRank statistics including a strong 4.1% yield, as well as being recognized by prominent asset managers as being a socially responsible investment, through analysis of social and environmental criteria. Environmental criteria include considerations [] The post Gilead Sciences a Top Socially Responsible Dividend Stock With 4.1% Yield (GILD) appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

Upcoming Ex-Dividend Dates: December 12-20, 2021

Gilead Sciences, Inc. (GILD) with the stream of -0.16% also noticed, India ChargePoint Holdings, Inc. (CHPT) encountered a rapid change of -7.39% in the last hour of trading session. Gilead The post OrganiGram Holdings Inc., NASDAQ:OGI, OGI NEWS, OGI STOCK, Gaotu Techedu Inc., NYSE:GOTU, GOTU NEWS, GOTU STOCK, OGI, GOTU appeared first on Stocks Equity .

Guild Esports plc (LON:GILD), a global team organisation and lifestyle brand, has announced the signing of Nicolas Villalba (Nicolas99fc) as the newest member of its FIFA roster. Nicolas, from Argentina, has ranked in the top 3 FIFA players worldwide since 2018 and is Argentinas second highest earner within esports, with $290,000 in lifetime earnings to []

Gilead Sciences Inc (NASDAQ: GILD) has issued a nationwide recall of two lots of its COVID-19 treatment drug Remdesivir because of the presence of glass particulates. Remdesivir, also known by its

Gilead is notifying distributors and customers about the problem.

Roche is optimally diversified both in terms of geography and in terms of portfolio. Pfizer and Eli Lilly are also broadly diversified but are more U.S.-centric companies. AbbVie, but also Merck are c

(Agency report) American biopharmaceutical company Gilead Sciences Inc. has issued a nationwide recall of two lots of its coronavirus treatment drug Remdesivir due to the presence of glass particulates, the

Gilead said Friday that it would carry out a voluntary recall of two lots of the coronavirus drug in the U.S. after determining that some vials were contaminated with glass.

Gilead Sciences announced a nationwide recall of 55,000 vials of its COVID-19 treatment drug remdesivir due to the "presence of glass particulates."

JJJ Advisors Inc. boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 29.6% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 757 shares of the biopharmaceutical companys stock after acquiring an additional 173 shares during the quarter. JJJ Advisors Inc.s holdings in []

A pharmaceutical manufacturer recalled thousands of vials of its COVID-19 antiviral drug remdesivir after an investigation found they were contaminated with glass particles.

Gilead Sciences Inc. is recalling 55,000 vials of the COVID-19 drug remdesivir in the US after after a complaint about glass particles was confirmed by a company investigation.